Femtrace Interactions
There are 363 drugs known to interact with Femtrace (estradiol), along with 17 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 29 are major, 314 are moderate, and 20 are minor.
- View all 363 medications that may interact with Femtrace
- View Femtrace alcohol/food interactions (3)
- View Femtrace disease interactions (17)
Most frequently checked interactions
View interaction reports for Femtrace (estradiol) and the medicines listed below.
- albuterol
- Allegra (fexofenadine)
- Altace (ramipril)
- Ambien (zolpidem)
- amphetamine / dextroamphetamine
- Apriso (mesalamine)
- Aspirin Low Strength (aspirin)
- atorvastatin
- baclofen
- Belsomra (suvorexant)
- Benadryl (diphenhydramine)
- Benadryl Allergy (diphenhydramine)
- benzonatate
- biotin
- Breyna (budesonide / formoterol)
- bupropion
- BuSpar (buspirone)
- caffeine
- Calcium 600 D (calcium / vitamin d)
- calcium / vitamin d
- cefuroxime
- Celebrex (celecoxib)
- Celexa (citalopram)
- cephalexin
- cetirizine
- cevimeline
- Fish Oil (omega-3 polyunsaturated fatty acids)
- gabapentin
- melatonin
- spironolactone
Femtrace alcohol/food interactions
There are 3 alcohol/food interactions with Femtrace (estradiol).
Femtrace disease interactions
There are 17 disease interactions with Femtrace (estradiol) which include:
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
More about Femtrace (estradiol)
- Femtrace consumer information
- Compare alternatives
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: estrogens
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.